BioOra
PrivateLast Round
Grant
Jun 19, 2026
Est. Valuation
$112.52M
Total Funding Raised
$26.74M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BioOra is a biotechnology company that develops and manufactures third-generation CAR T-cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioOra Comparables
Compare BioOra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wellington Zhaotai Therapies Limited | 78% | |
| Galapagos NV | 74% | |
| Resilience | 68% | |
BioOra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 19, 2026 | ||||
| Series A Extension | Jun 4, 2026 | ||||
| Series A | Oct 2, 2025 | ||||
| Series A Extension | Sep 1, 2025 | ||||
| VC Round | Apr 1, 2025 | ||||
Early Funding | Nov 22, 2024 |
BioOra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Seed |
| Bridgewest Ventures | Series A, Early Funding, Seed, VC Round |
| Queensland Government | Grant |
| Mainland Angel Investors | Early Funding, VC Round, Series A Extension |
| Cure Kids Ventures | Early Funding |
| Angel Investors Marlborough | Early Funding |
| Booster Innovation Fund | Early Funding, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Open roles increased to 10, 2.6x the trailing average.
- Jun 15, 2026
Open roles increased to 9, representing 20% of headcount.
BioOra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioOra's valuation, stock price, and market status.